Advertisement
Advertisement

PVLA

PVLA logo

Palvella Therapeutics, Inc. Common Stock

120.57
USD
Sponsored
-5.22
-4.15%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

120.09

-0.48
-0.40%

Palvella Therapeutics, Inc. Common Stock Profile

About

Palvella Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. Palvella Therapeutics Inc., formerly known as Pieris Pharmaceuticals Inc., is based in WAYNE, Pa.

Info & Links

CEO

Wesley H. Kaupinen

Headquarters

353 W. Lancaster Ave, Suite 200
Wayne, PA 19087, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://palvellatx.com

Auditor

Ernst & Young LLP

Share holders

52

Employees

29

Palvella Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.72B

Enterprise Value

1.66B

Enterprise Value/EBITDA(ttm)

-43.12

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

55.07

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-98.14%

Return on Invested Capital(ttm)

-70.19%

Return on Assets(ttm)

-59.66%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-38.60M

Net Income Available to Common(ttm)

-41.72M

Diluted EPS(ttm)

-3.71

Share Statistics

Beta (5Y Monthly)

-0.21

52-Week Change

421.50%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

14.31M

Dividend Yield

0.00%

Float4

11.38M

% Held by Insiders

20.50%

% Held by Institutions

40.11%

Balance Sheet

Total Cash(mrq)

57.98M

Total Cash Per Share(mrq)

4.05

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.49%

Quick Ratio(mrq)

5.20%

Book Value Per Share(mrq)

3.49

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.81

Free Cash Flow(ytd)

-20.08M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement